☆ 4.7 Article

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play A Report of the American College of Cardiology Solution Set Oversight Committee

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Volume 79, Issue 17, Pages 1717-1756

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.jacc.2022.02.003

Keywords

ACC Expert Consensus Decision Pathway; athletes; cardiovascular diseases; chest pain; COVID-19; myocarditis; SARS-CoV-2; sports medicine; vaccines

Categories

Cardiac & Cardiovascular Systems

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Biochemistry & Molecular Biology

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence

Altijana Hromic-Jahjefendic, Abas Sezer, Alaa A. A. Aljabali, Angel Serrano-Aroca, Murtaza M. Tambuwala, Vladimir N. Uversky, Elrashdy M. Redwan, Debmalya Barh, Kenneth Lundstrom

Summary: COVID-19 vaccines have been widely used to reduce the incidence and disease severity of COVID-19. Recent concerns have been raised about a possible association between COVID-19 vaccines and myocarditis. Myocarditis can be caused by infections, immune reactions, or toxic exposure. The incidence rate of myocarditis after vaccination is lower than that after SARS-CoV-2 infection, and it is more common in adolescent males following mRNA vaccination.

BIOMEDICINES (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes

Nathaniel Moulson, Bradley J. Petek, Jonathan A. Drezner, Kimberly G. Harmon, Stephanie A. Kliethermes, Manesh R. Patel, Aaron L. Baggish

Summary: This study investigated the prevalence and clinical implications of COVID-19 cardiac involvement in young competitive athletes in the United States. The results showed a low prevalence of cardiac involvement and a low risk of clinical events in short-term follow-up among these athletes.

CIRCULATION (2021)

Add to Collection

Editorial Material Virology

Diagnosis of Acute Myocarditis Following mRNA Vaccines against SARS-CoV-2: A Methodological Review

Marco Zuin, Emma Zimelli, Chiara Dalla Valle, Stefano Cavedon, Gianluca Rigatelli, Claudio Bilato

Summary: The occurrence of acute myocarditis following mRNA vaccines against SARS-CoV-2 is rare with low mortality rate, but diagnosis remains challenging. Two cases from a hospital in Italy were studied to investigate the relationship between myocarditis and SARS-CoV-2 mRNA vaccines, and a literature review was conducted to identify clinical and diagnostic elements that could raise suspicion of myocarditis as an adverse event of SARS-CoV-2 immunization.

VIRUSES-BASEL (2023)

Add to Collection

Review Medicine, General & Internal

Covid-19 Vaccines - Immunity, Variants, Boosters

Dan H. Barouch

Summary: This article reviews the protective effects of vaccination and prior infection on severe Covid-19, and proposes future research directions.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocarditis With COVID-19 mRNA Vaccines

Biykem Bozkurt, Ishan Kamat, Peter J. Hotez

Summary: Myocarditis is a rare complication of COVID-19 mRNA vaccines, predominantly affecting young adult and adolescent males, with most patients showing improvement in symptoms. Possible mechanisms include molecular mimicry between viral proteins and self-antigens, dysregulated immune pathways, immune response to mRNA, and dysregulated cytokine expression.

CIRCULATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Humoral and cellular immune memory to four COVID-19 vaccines

Zeli Zhang, Jose Mateus, Camila H. Coelho, Jennifer M. Dan, Carolyn Rydyznski Moderbacher, Rosa Isela Galvez, Fernanda H. Cortes, Alba Grifoni, Alison Tarke, James Chang, E. Alexandar Escarrega, Christina Kim, Benjamin Goodwin, Nathaniel Bloom, April Frazier, Daniela Weiskopf, Alessandro Sette, Shane Crotty

Summary: Multiple COVID-19 vaccines have successfully protected against symptomatic cases and deaths. Comparisons of T cell, B cell, and antibody responses to different vaccines can provide insights into protective immunity against COVID-19, particularly immune memory. mRNA vaccines and Ad26.COV2.S induced strong T cell responses, while mRNA vaccines showed substantial declines in antibodies.

CELL (2022)

Add to Collection

News Item Multidisciplinary Sciences

HOW NASAL-SPRAY VACCINES COULD CHANGE THE PANDEMIC

Emily Waltz

Summary: Vaccines that are inhaled through the nose or mouth could potentially halt the spread of the coronavirus, but there is currently limited evidence from human trials.

NATURE (2022)

Add to Collection

Article Hematology

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

Ismail Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, Jean-Pierre Laroche, Patrick Van Dreden, Walter Ageno, Jan Beyer-Westendorf, Alexander T. Cohen, David Jimenez, Benjamin Brenner, Saskia Middeldorp, Patrice Cacoub

Summary: Vaccination strategies developed in the latter half of the 20th century helped eradicate infectious diseases, but concerns have arisen over thrombotic events associated with some SARS-CoV-2 vaccines during the COVID-19 pandemic. In response to these challenges, a panel of experts has proposed a tracking algorithm based on a 10-point guideline for decision-making.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Myocarditis associated with COVID-19 and its vaccines-a systematic review

Amit Rout, Sarabjeet Suri, Mounica Vorla, Dinesh K. Kalra

Summary: Since the COVID-19 pandemic began, myocarditis has been a worrisome cardiovascular complication and has also been recognized as an important vaccine-related adverse event. COVID vaccine-induced myocarditis is more common in young males, while COVID-19 viral myocarditis can range from mild to severe. Diagnosis is based on clinical features, laboratory investigations, and imaging, with cardiac magnetic resonance preferred. Supportive care is the main treatment for COVID-19 myocarditis, while severe cases may require advanced heart failure therapies. Despite the small risk of vaccine-induced myocarditis, the benefits of COVID-19 vaccination outweigh the risks.

PROGRESS IN CARDIOVASCULAR DISEASES (2022)

Add to Collection

Editorial Material Multidisciplinary Sciences

COVID vaccines: time to confront anti-vax aggression

Peter Hotez

Summary: To halt the spread of the coronavirus, a high-level counteroffensive against new destructive forces is necessary.

NATURE (2021)

Add to Collection

Article Immunology

Impact of COVID-19 Vaccination on Short-Term Perceived Change in Physical Performance among Elite Athletes: An International Survey

Olivier Bruyere, Geraldine Martens, Celine Demonceau, Axel Urhausen, Romain Seil, Suzanne Leclerc, Sebastien Le Garrec, Philippe Le Van, Pascal Edouard, Philippe M. Tscholl, Francois Delvaux, Jean-Francois Toussaint, Jean-Francois Kaux

Summary: An online survey was conducted among elite athletes to assess the impact of COVID-19 vaccination on physical performance. Results showed that 72% of athletes perceived no change, 4% perceived improvement, and 24% perceived a negative impact on physical performance following full vaccination. Factors such as individual sport, longer duration of vaccine reactions, higher level of vaccine reaction, and perceived pressure to get vaccinated were associated with a negative impact on physical performance lasting more than 3 days.

VACCINES (2023)

Add to Collection

Editorial Material Multidisciplinary Sciences

The next generation of coronavirus vaccines: a graphical guide

Ewen Callaway

Summary: New technologies may offer stronger or wider immunity, but they will face competition for market share.

NATURE (2023)

Add to Collection

Article Cell & Tissue Engineering

Modified mRNA-Based Vaccines Against Coronavirus Disease 2019

Aline Yen Ling Wang

Summary: The COVID-19 pandemic has presented a significant challenge to global healthcare and economic systems. The development of modRNA vaccines has allowed for a rapid response to the virus, with promising effectiveness against infection. However, long-term safety and protective immunity still require further investigation.

CELL TRANSPLANTATION (2022)

Add to Collection

News Item Multidisciplinary Sciences

DOSING DECISIONS: COULD COVID VACCINES HAVE WORKED BETTER?

Elie Dolgin

Summary: In the scramble to combat the pandemic, vaccine dosing decisions relied on past experience and best guesses, with modelling tools potentially playing a role.

NATURE (2022)

Add to Collection

Letter Medicine, General & Internal

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines

Xin Zhao, Rong Zhang, Shitong Qiao, Xiao Wang, Weibing Zhang, Wenjing Ruan, Lianpan Dai, Pengcheng Han, George F. Gao

Summary: This study found that neutralization against the SARS-CoV-2 omicron subvariants was reduced with both the inactivated and ZF2001 vaccines in China. However, heterologous boosting and a longer interval between doses resulted in higher neutralization levels.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Inflammatory and thrombotic valvulopathies in autoimmune disease

Yevgeniya Gartshteyn, Nicole Bhave, Megan Shetty Joseph, Anca Askanase, Elana Bernstein

Summary: Rheumatologic diseases can cause inflammation and scarring of the endocardium, leading to valvular thickening and dysfunction. The progression of valve disease is slow but can result in significant complications. The presence of antiphospholipid antibodies increases the risk of valvular disease and thrombotic complications. Management of valvular disease requires a multidisciplinary approach, with medical therapy optimized and consideration of high-risk valve surgery if necessary.

HEART (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care

Kim K. Birtcher, Larry A. Allen, Jeffrey L. Anderson, Mikhail Kosiborod, Laxmi S. Mehta, Salim S. Virani, Marc P. Bonaca, Ty J. Gluckman, Aliza Hussain, Nicole M. Bhave, Niti R. Aggarwal, Biykem Bozkurt, John P. Erwin, Chayakrit Krittanawong, Dharam J. Kumbhani, Gurusher S. Panjrath, Javier A. Sala-Mercado, David E. Winchester, Megan Coylewright

Summary: Atherosclerotic cardiovascular disease (ASCVD) is a common chronic condition worldwide, often accompanied by other chronic diseases. The treatment of patients with ASCVD and multimorbidity can be complex and burdensome. Therefore, clinicians need guidance on how to manage ASCVD progression and adverse cardiovascular events, while considering other chronic conditions and patient preferences.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Heart Failure Drug Treatment- Inertia, Titration, and Discontinuation

Gianluigi Savarese, Takuya Kishi, Orly Vardeny, Samuel Adamsson Eryd, Johan Bodegard, Lars H. Lund, Marcus Thuresson, Biykem Bozkurt

Summary: This study examined the use of guideline-directed medical therapies (GDMTs) in Japan, Sweden, and the United States. It found that initiation of novel GDMTs was delayed compared to other GDMTs and only a small percentage of patients received the target doses of the recommended GDMTs.

JACC-HEART FAILURE (2023)

Add to Collection

Article Health Care Sciences & Services

Patient Experience with Telemedicine in Adults with Congenital Heart Disease

Anudeep K. K. Dodeja, Matthew Schreier, Matthew Granger, Deborah Mitchell, Rosemary Chumita, Tracey Sisk, Curt J. J. Daniels, Saurabh Rajpal

Summary: The COVID-19 pandemic has led to increased use of telemedicine. Limited data on patient experience with telemedicine in adults with congenital heart disease (ACHD) exist. However, a survey found that most ACHD patients had a positive experience with telemedicine and would prefer it over in-person clinic visits.

TELEMEDICINE AND E-HEALTH (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers The ARIC Study

Xiaoming Jia, Mahmoud Al Rifai, Chiadi E. Ndumele, Salim S. Virani, James A. de Lemos, Emmanuel Lee, Amil M. Shah, Justin B. Echouffo-Tcheugui, Biykem Bozkurt, Ron Hoogeveen, Elizabeth Selvin, Christie M. Ballantyne, Vijay Nambi

Summary: This study evaluated the impact of incorporating cardiac biomarkers in reclassifying heart failure (HF) and assessed the prognosis of HF using these biomarkers. The results showed that approximately 1 in 5 older adults without prevalent HF were reclassified as Stage B HF, and the measurement of cardiac biomarkers can help identify individuals at higher HF risk.

JACC-HEART FAILURE (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Treatment of Advanced (Stage D) Heart Failure in the New Era

Biykem Bozkurt

JACC-HEART FAILURE (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines

Biykem Bozkurt

CIRCULATION (2023)

Add to Collection

Article Gastroenterology & Hepatology

Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac events

Dempsey L. Hughes, Jason Pan, Adeline R. Answine, Christopher J. Sonnenday, Seth A. Waits, Sathish S. Kumar, Daniel S. Menees, Brett Wanamaker, Nicole M. Bhave, Monica A. Tincopa, Robert J. Fontana, Pratima Sharma

Summary: Positron emission tomography myocardial perfusion imaging (PET MPI) is a noninvasive diagnostic test that can detect coronary artery disease, structural heart disease, and myocardial flow reserve (MFR). This study aimed to determine the prognostic utility of PET MPI in predicting major adverse cardiac events (MACE) after liver transplant (LT). Reduced global MFR and reduced resting left ventricular ejection fraction on pre-LT PET MPI were associated with an increased risk of post-LT MACE. Awareness of these PET-MPI parameters may help improve cardiac risk stratification of LT candidates if confirmed in future studies.

LIVER TRANSPLANTATION (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Myocardial Inflammation and Fibrosis Are Associated With Reduced Strain in Collegiate Athletes Recovering From SARS-CoV-2

John L. Heyniger, Katarzyna E. Gil, Brett G. Klamer, Kan N. Hor, Lauren Ledingham, Simon Lee, Matthew S. Tong, Orlando P. Simonetti, Saurabh Rajpal

JACC-CARDIOVASCULAR IMAGING (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death

Xiaoming Jia, Mahmoud Al Rifai, Ron Hoogeveen, Justin B. Echouffo-Tcheugui, Amil M. M. Shah, Chiadi E. Ndumele, Salim S. Virani, Biykem Bozkurt, Elizabeth Selvin, Christie M. Ballantyne, Vijay Nambi

Summary: This study assessed the association between change in NT-proBNP and the risk for incident heart failure and death. The results showed that change in NT-proBNP was positively correlated with the risk of heart failure and death. Additionally, changes in blood pressure, cholesterol, triglyceride levels, body mass index, and estimated glomerular filtration rate were associated with change in NT-proBNP.

JAMA CARDIOLOGY (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Optimizing outcomes in heart failure: 2022 and beyond

Ewa A. Jankowska, Tomas Andersson, Claudia Kaiser-Albers, Biykem Bozkurt, Ovidiu Chioncel, Andrew J. S. Coats, Loreena Hill, Friedrich Koehler, Lars H. Lund, Theresa McDonagh, Marco Metra, Clemens Mittmann, Wilfried Mullens, Uwe Siebert, Scott D. Solomon, Maurizio Volterrani, John J. V. McMurray

Summary: Despite the rapid development of therapies and tools for heart failure (HF), everyday management in clinical practice remains suboptimal. A workshop convened by the European Society of Cardiology (ESC) identified barriers, such as the complexity of HF and its treatment, financial constraints, failure to meet patient needs, suboptimal outpatient management, and fragmented healthcare systems. Ongoing initiatives and proposed actions aim to address these barriers and improve patient outcomes.

ESC HEART FAILURE (2023)

Add to Collection

Editorial Material Oncology

JACC Journals' Pathway Forward With AI Tools

Valentin Fuster, Biykem Bozkurt, Y. Chandrashekhar, Julia Grapsa, Bonnie Ky, Douglas L. Mann, David J. Moliterno, Kalyanam Shivkumar, Candice K. Silversides, Justine Varieur Turco, Jian'an Wang

Summary: Advanced software computational technologies, such as AI, are influencing various aspects of life, including healthcare and science. In scientific publishing, AI technologies are increasingly being used to assist authors in improving the preparation and quality of their manuscripts. These technologies include software style and grammar correction, as well as statistical analysis.

JACC: CARDIOONCOLOGY (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines (vol 79, pg e263, 2022)

P. A. Paul A. Heidenreich, B. Bozkurt

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Correction Cardiac & Cardiovascular Systems

Aiming at harmony. Comparing and contrasting International HFrEF Guidelines (vol 24, pg L20, 2022)

Daniela Tomasoni, Marianna Adamo, Biykem Bozkurt, Paul Heidenreich, Theresa McDonagh, Giuseppe M. C. Rosano, Sean A. Virani, Shelley Zieroth, Marco Metra

EUROPEAN HEART JOURNAL SUPPLEMENTS (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Novel uses for implanted haemodynamic monitoring in adults with subaortic right ventricles

William H. Marshall, May Ling Mah, Jennifer Desalvo, Saurabh Rajpal, Lauren T. Lastinger, Arash Salavitabar, Aimee K. Armstrong, Darren Berman, Brent Lampert, Lydia K. Wright, Jenne Hickey, Rachel Metzger, Deipanjan Nandi, Robert Gajarski, Curt J. Daniels

Summary: This study describes novel uses of implantable invasive hemodynamic monitoring (IHM) in patients with subaortic right ventricles (sRV), which may minimize the need for serial catheterizations and improve management in a population where pulmonary hypertension (PH) is prevalent. The findings suggest that IHM can be used for medical therapy titration, medical management after ventricular assist device, and serial monitoring of pulmonary artery pressures. There were low rates of heart failure hospitalization and device-related complications, indicating that IHM is a safe and effective tool in this patient population.

HEART (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.